BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27652671)

  • 1. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.
    Moreira AS; Mil-Homens D; Sousa SA; Coutinho CP; Pinto-de-Oliveira A; Ramos CG; Dos Santos SC; Fialho AM; Leitão JH; Sá-Correia I
    Virulence; 2017 Aug; 8(6):782-796. PubMed ID: 27652671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental Burkholderia cenocepacia Strain Enhances Fitness by Serial Passages during Long-Term Chronic Airways Infection in Mice.
    Bragonzi A; Paroni M; Pirone L; Coladarci I; Ascenzioni F; Bevivino A
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135920
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic diversity and genotypic flexibility of
    Lee AH; Flibotte S; Sinha S; Paiero A; Ehrlich RL; Balashov S; Ehrlich GD; Zlosnik JE; Mell JC; Nislow C
    Genome Res; 2017 Apr; 27(4):650-662. PubMed ID: 28325850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
    Silva IN; Ferreira AS; Becker JD; Zlosnik JEA; Speert DP; He J; Mil-Homens D; Moreira LM
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3124-3137. PubMed ID: 21835880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
    Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
    mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.
    Coutinho CP; de Carvalho CC; Madeira A; Pinto-de-Oliveira A; Sá-Correia I
    Infect Immun; 2011 Jul; 79(7):2950-60. PubMed ID: 21536796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis of Burkholderia cenocepacia isolated from a liver abscess in a patient with cystic fibrosis.
    de Freitas Vianna E; Menezes NIM; de Almeida MM; de Freitas FAD; da Costa Ferreira Leite C; Firmida MC; de Medeiros DRI; Souza Leão R; Mattos Albano R; Andrade Marques E
    APMIS; 2021 Nov; 129(11):631-640. PubMed ID: 34561922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.
    Agnoli K; Freitag R; Gomes MC; Jenul C; Suppiger A; Mannweiler O; Frauenknecht C; Janser D; Vergunst AC; Eberl L
    Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28432094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.
    Schwager S; Agnoli K; Köthe M; Feldmann F; Givskov M; Carlier A; Eberl L
    Infect Immun; 2013 Jan; 81(1):143-53. PubMed ID: 23090963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of Burkholderia cenocepacia cell wall morphology and mechanical properties during cystic fibrosis lung infection, assessed by atomic force microscopy.
    Hassan AA; Vitorino MV; Robalo T; Rodrigues MS; Sá-Correia I
    Sci Rep; 2019 Nov; 9(1):16118. PubMed ID: 31695169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the genome diversity and virulence of two clinical isolates of Burkholderia cenocepacia.
    Salloum T; Nassour E; Araj GF; Abboud E; Tokajian S
    J Med Microbiol; 2018 Aug; 67(8):1157-1167. PubMed ID: 29897328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.
    Miller RR; Hird TJ; Tang P; Zlosnik JE
    PLoS One; 2015; 10(11):e0143472. PubMed ID: 26599356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia multivorans survival and trafficking within macrophages.
    Schmerk CL; Valvano MA
    J Med Microbiol; 2013 Feb; 62(Pt 2):173-184. PubMed ID: 23105020
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 17. The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.
    Silva IN; Pessoa FD; Ramires MJ; Santos MR; Becker JD; Cooper VS; Moreira LM
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29914989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRP/FNR family protein Bcam1349 is a c-di-GMP effector that regulates biofilm formation in the respiratory pathogen Burkholderia cenocepacia.
    Fazli M; O'Connell A; Nilsson M; Niehaus K; Dow JM; Givskov M; Ryan RP; Tolker-Nielsen T
    Mol Microbiol; 2011 Oct; 82(2):327-41. PubMed ID: 21883527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia.
    Springman AC; Jacobs JL; Somvanshi VS; Sundin GW; Mulks MH; Whittam TS; Viswanathan P; Gray RL; Lipuma JJ; Ciche TA
    Appl Environ Microbiol; 2009 Aug; 75(16):5250-60. PubMed ID: 19542323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Burkholderia cenocepacia non-coding RNAs expressed during Caenorhabditis elegans infection.
    Pita T; Feliciano JR; Leitão JH
    Appl Microbiol Biotechnol; 2023 Jun; 107(11):3653-3671. PubMed ID: 37097504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.